|
|
Stay in the know about Adequan® Canine Get connected! Join our community of pet parents and save $15 on Adequan® Canine (polysulfated glycosaminoglycan). Plus, receive exclusive offers, rebates, and joint health tips to help keep your dog moving for a lifetime of adventure. (Details on how to redeem your $15 rebate will be sent to the email address provided below upon submission of this form.) |
*Indicates required field |
|
Adequan® Canine polysulfated glycosaminoglycan (PSGAG) solution 100 mg/mL Indications and Usage Adequan® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. IMPORTANT SAFETY INFORMATION Adequan® Canine should not be used in dogs who are hypersensitive to polysulfated glycosaminoglycan (PSGAG) or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Adverse reactions in clinical studies (transient pain at injection site, transient diarrhea, and abnormal bleeding) were mild and self-limiting. In post approval experience, death has been reported in some cases; vomiting, anorexia, depression/lethargy and diarrhea have also been reported. The safe use of PSGAG in breeding, pregnant or lactating dogs has not been evaluated. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see full prescribing information at adequancanine.com. |
Your information will be used by American Regent Animal Health to send you news and information about canine osteoarthritis, Adequan® Canine and other American Regent Animal Health products. We may use your information to help target future content, so we are only sending you relevant information. We will never sell your information to unaffiliated third parties. Once you start receiving news and information, you may opt out from future communications at any time. All trademarks are the property of American Regent, Inc. © 2024, American Regent, Inc. PP-AC-US-0700 |